J David Enloe Jr

CIK 1201526 · Chief Executive Officer · last filed 2024-04-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$589.1K

Companies

Total Filings

Lifetime Open-Market Net

$65.1K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

SCTL price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

Recro Pharma, Inc. — 23 joint filings, latest 2024-04-08

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Societal CDMO, Inc. (SCTL) Delisted	Chief Executive Officer	0	$1.10	$0	$58.2K	15	2024-04-08
Societal CDMO, Inc. (REPH) Delisted	Chief Executive Officer	524,879	$2.09	$1.10M	$6.9K	7	2022-03-17
INGN	Sr. Vice President	83,200	$7.08	$589.1K	$0	3	2008-05-20

Recent Filings · Page 2 of 3

25 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-07-18	Societal CDMO, Inc. (SCTL) Delisted	Buy (P)	+1,150	$931	EDGAR
2022-06-17	Societal CDMO, Inc. (SCTL) Delisted	Buy (P)	+1,562	$1.1K	EDGAR
2022-05-18	Societal CDMO, Inc. (SCTL) Delisted	Buy (P)	+1,086	$1.0K	EDGAR
2022-04-20	Societal CDMO, Inc. (SCTL) Delisted	Buy (P)	+625	$1.0K	EDGAR
2022-04-04	Societal CDMO, Inc. (SCTL) Delisted	Tax (F)	−22,590	-$37.3K	EDGAR
2022-03-17	Societal CDMO, Inc. (REPH) Delisted	Buy (P)	+512	$1.0K	EDGAR
2022-02-17	Societal CDMO, Inc. (REPH) Delisted	Buy (P)	+571	$1.0K	EDGAR
2022-01-24	Societal CDMO, Inc. (REPH) Delisted	Grant (A)	+369,037	$0	EDGAR
2022-01-19	Societal CDMO, Inc. (REPH) Delisted	Buy (P)	+602	$1.0K	EDGAR
2021-12-17	Societal CDMO, Inc. (REPH) Delisted	Buy (P)	+617	$993	EDGAR

Showing 11–20 of 25

Prev Page 2 of 3 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.